Loading...

Victoria Risbrough

Title(s)Professor In Residence, Psychiatry
SchoolHealth Sciences
Address9500 Gilman Drive #0804
La Jolla CA 92093
Phone619-543-2900
vCardDownload vCard

    Collapse Overview 
    Collapse Overview

    Biography

    Dr. Risbrough received her B.A. degree in Psychology and her Ph.D. in Neuroscience from the University of California, San Diego. She joined as faculty in the Department of Psychiatry at UCSD in 2007 and became Associate Professor in 2012. She is the Associate Director of Neuroscience for the Center of Excellence for Stress and Mental Health at the San Diego Veterans Healthcare System. Dr. Risbrough is the Principal Investigator on awards from the National Institute of Mental Health, NARSAD, Veteran’s Affairs and the U.S. Department of Defense. She is also Director of the Neurocognition Project for the Marine Resiliency Study funded by Navy BUMED. She was the Guest Editor for the Special Issue on PTSD for Neuropharmacology and is an Associate Editor for a number of pharmacology journals. She is also a member of the Molecular Neuropharmacology and Signaling study section for NIH. Dr. Risbrough’s research is centered on translational mechanisms and treatments of anxiety disorders using preclinical and clinical approaches. Her primary focus is to identify mechanisms of risk and resilience to anxiety disorders, particularly posttraumatic stress disorder as well as development of new pharmacological treatments for these disorders. For example, she examines the contribution of corticotropin releasing factor to stress and anxiety responses using pharmacological and genetic techniques in mice. Her program also identifies genetic and environmental contributions to stress behavior and fear learning. For example she has recently been funded to examine the role of the COMTVal158Met polymorphism in PTSD risk and treatment response. By measuring physiological responses to stress (including heart rate and startle reactivity) in animal models and in clinic, her research develops translational probes of anxiety responding and treatment efficacy.

    Research Interests

    Dr. Risbrough’s research is centered on translational mechanisms and treatments of anxiety disorders using preclinical and clinical approaches. Her primary focus is understanding mechanisms of risk and resilience to anxiety disorders, particularly post-traumatic stress disorder. For example, she examines the contribution of corticotropin releasing factor to stress and anxiety responses using pharmacological and genetic techniques in mice. Her program also identifies genetic and environmental contributions to stress behavior and fear learning. By measuring physiological responses to stress (including heart rate and startle reactivity) in animal models and in clinic, her research develops translational probes of anxiety responding and treatment efficacy.

    Clinical Focus

    The goal of our work is to understand the basic mechanisms underlying anxiety and fear responses, as well as to identify biological factors contributing to the risk of and resilience to development of anxiety disorders. With this information we hope to develop better measures of treatment response in anxiety disorders and identify novel targets of pharmacotherapeutics.

    Collapse Research 
    Collapse Research Activities and Funding
    Neuronal exosomes to identify biomarkers and pathology of deployment-related TBI
    VA I01BX004312Oct 1, 2018 - Sep 30, 2022
    Role: Principal Investigator
    Developing rodent models of PTSD/AUD: leveraging clinic-based strategies
    NIH/NIAAA R01AA026560Sep 12, 2017 - Aug 31, 2022
    Role: Principal Investigator
    Role of COMTval158met in PTSD risk and treatment response
    VA I01BX002558Oct 1, 2014 - Sep 30, 2018
    Role: Principal Investigator
    Understanding the Role of COMT Variants in Sensorimotor Gating
    NIH/NIMH R33MH083499May 15, 2008 - Apr 30, 2012
    Role: Principal Investigator
    Understanding the Role of COMT Variants in Sensorimotor Gating
    NIH/NIMH R21MH083499May 15, 2008 - Apr 30, 2010
    Role: Principal Investigator
    Murine model of CRF effects on fear extinction: relevance to PTSD
    NIH/NIMH R21MH076850May 5, 2006 - Apr 30, 2009
    Role: Principal Investigator
    Stress and CRF System Effects on Information Processing
    NIH/NIMH R01MH074697Jul 1, 2005 - Feb 28, 2015
    Role: Principal Investigator
    Role of CRF and 5-HT1A receptors in ASR
    NIH/NIMH F31MH068133Apr 1, 2003 - Mar 31, 2005
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Websites
    Collapse Faculty Mentoring

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Analysis of Genetically Regulated Gene Expression Identifies a Prefrontal PTSD Gene, SNRNP35, Specific to Military Cohorts. Cell Rep. 2020 Jun 02; 31(9):107716. Huckins LM, Chatzinakos C, Breen MS, Hartmann J, Klengel T, da Silva Almeida AC, Dobbyn A, Girdhar K, Hoffman GE, Klengel C, Logue MW, Lori A, Maihofer AX, Morrison FG, Nguyen HT, Park Y, Ruderfer D, Sloofman LG, van Rooij SJH, Baker DG, Chen CY, Cox N, Duncan LE, Geyer MA, Glatt SJ, Im HK, Risbrough VB, Smoller JW, Stein DJ, Yehuda R, Liberzon I, Koenen KC, Jovanovic T, Kellis M, Miller MW, Bacanu SA, Nievergelt CM, Buxbaum JD, Sklar P, Ressler KJ, Stahl EA, Daskalakis NP. PMID: 32492425.
      View in: PubMed   Mentions:    Fields:    
    2. An epigenome-wide association study of posttraumatic stress disorder in US veterans implicates several new DNA methylation loci. Clin Epigenetics. 2020 Mar 14; 12(1):46. Logue MW, Miller MW, Wolf EJ, Huber BR, Morrison FG, Zhou Z, Zheng Y, Smith AK, Daskalakis NP, Ratanatharathorn A, Uddin M, Nievergelt CM, Ashley-Koch AE, Baker DG, Beckham JC, Garrett ME, Boks MP, Geuze E, Grant GA, Hauser MA, Kessler RC, Kimbrel NA, Maihofer AX, Marx CE, Qin XJ, Risbrough VB, Rutten BPF, Stein MB, Ursano RJ, Vermetten E, Vinkers CH, Ware EB, Stone A, Schichman SA, McGlinchey RE, Milberg WP, Hayes JP, Verfaellie M. PMID: 32171335.
      View in: PubMed   Mentions:    Fields:    
    3. Genomic influences on self-reported childhood maltreatment. Transl Psychiatry. 2020 Jan 27; 10(1):38. Dalvie S, Maihofer AX, Coleman JRI, Bradley B, Breen G, Brick LA, Chen CY, Choi KW, Duncan LE, Guffanti G, Haas M, Harnal S, Liberzon I, Nugent NR, Provost AC, Ressler KJ, Torres K, Amstadter AB, Bryn Austin S, Baker DG, Bolger EA, Bryant RA, Calabrese JR, Delahanty DL, Farrer LA, Feeny NC, Flory JD, Forbes D, Galea S, Gautam A, Gelernter J, Hammamieh R, Jett M, Junglen AG, Kaufman ML, Kessler RC, Khan A, Kranzler HR, Lebois LAM, Marmar C, Mavissakalian MR, McFarlane A, Donnell MO, Orcutt HK, Pietrzak RH, Risbrough VB, Roberts AL, Rothbaum AO, Roy-Byrne P, Ruggiero K, Seligowski AV, Sheerin CM, Silove D, Smoller JW, Stein MB, Teicher MH, Ursano RJ, Van Hooff M, Winternitz S, Wolff JD, Yehuda R, Zhao H, Zoellner LA, Stein DJ, Koenen KC, Nievergelt CM. PMID: 32066696.
      View in: PubMed   Mentions: 1     Fields:    
    4. Longitudinal epigenome-wide association studies of three male military cohorts reveal multiple CpG sites associated with post-traumatic stress disorder. Clin Epigenetics. 2020 Jan 13; 12(1):11. Snijders C, Maihofer AX, Ratanatharathorn A, Baker DG, Boks MP, Geuze E, Jain S, Kessler RC, Pishva E, Risbrough VB, Stein MB, Ursano RJ, Vermetten E, Vinkers CH, Smith AK, Uddin M, Rutten BPF, Nievergelt CM. PMID: 31931860.
      View in: PubMed   Mentions:    Fields:    
    5. Angiotensin II Signaling and Fear Extinction: Translational Evidence and Novel Receptor Targets. Biol Psychiatry. 2019 12 15; 86(12):874-876. Stout DM, Risbrough VB. PMID: 31753101.
      View in: PubMed   Mentions:    Fields:    Translation:Cells
    6. Impact of TBI, PTSD, and Hearing Loss on Tinnitus Progression in a US Marine Cohort. Mil Med. 2019 12 01; 184(11-12):839-846. Clifford RE, Baker D, Risbrough VB, Huang M, Yurgil KA. PMID: 30793178.
      View in: PubMed   Mentions:    Fields:    
    7. Sleep disturbance at pre-deployment is a significant predictor of post-deployment re-experiencing symptoms. Eur J Psychotraumatol. 2019; 10(1):1679964. Acheson DT, Kwan B, Maihofer AX, Risbrough VB, Nievergelt CM, Clark JW, Tu XM, Irwin MR, Baker DG. PMID: 31723377.
      View in: PubMed   Mentions:
    8. International meta-analysis of PTSD genome-wide association studies identifies sex- and ancestry-specific genetic risk loci. Nat Commun. 2019 10 08; 10(1):4558. Nievergelt CM, Maihofer AX, Klengel T, Atkinson EG, Chen CY, Choi KW, Coleman JRI, Dalvie S, Duncan LE, Gelernter J, Levey DF, Logue MW, Polimanti R, Provost AC, Ratanatharathorn A, Stein MB, Torres K, Aiello AE, Almli LM, Amstadter AB, Andersen SB, Andreassen OA, Arbisi PA, Ashley-Koch AE, Austin SB, Avdibegovic E, Babic D, Bækvad-Hansen M, Baker DG, Beckham JC, Bierut LJ, Bisson JI, Boks MP, Bolger EA, Børglum AD, Bradley B, Brashear M, Breen G, Bryant RA, Bustamante AC, Bybjerg-Grauholm J, Calabrese JR, Caldas-de-Almeida JM, Dale AM, Daly MJ, Daskalakis NP, Deckert J, Delahanty DL, Dennis MF, Disner SG, Domschke K, Dzubur-Kulenovic A, Erbes CR, Evans A, Farrer LA, Feeny NC, Flory JD, Forbes D, Franz CE, Galea S, Garrett ME, Gelaye B, Geuze E, Gillespie C, Uka AG, Gordon SD, Guffanti G, Hammamieh R, Harnal S, Hauser MA, Heath AC, Hemmings SMJ, Hougaard DM, Jakovljevic M, Jett M, Johnson EO, Jones I, Jovanovic T, Qin XJ, Junglen AG, Karstoft KI, Kaufman ML, Kessler RC, Khan A, Kimbrel NA, King AP, Koen N, Kranzler HR, Kremen WS, Lawford BR, Lebois LAM, Lewis CE, Linnstaedt SD, Lori A, Lugonja B, Luykx JJ, Lyons MJ, Maples-Keller J, Marmar C, Martin AR, Martin NG, Maurer D, Mavissakalian MR, McFarlane A, McGlinchey RE, McLaughlin KA, McLean SA, McLeay S, Mehta D, Milberg WP, Miller MW, Morey RA, Morris CP, Mors O, Mortensen PB, Neale BM, Nelson EC, Nordentoft M, Norman SB, O'Donnell M, Orcutt HK, Panizzon MS, Peters ES, Peterson AL, Peverill M, Pietrzak RH, Polusny MA, Rice JP, Ripke S, Risbrough VB, Roberts AL, Rothbaum AO, Rothbaum BO, Roy-Byrne P, Ruggiero K, Rung A, Rutten BPF, Saccone NL, Sanchez SE, Schijven D, Seedat S, Seligowski AV, Seng JS, Sheerin CM, Silove D, Smith AK, Smoller JW, Sponheim SR, Stein DJ, Stevens JS, Sumner JA, Teicher MH, Thompson WK, Trapido E, Uddin M, Ursano RJ, van den Heuvel LL, Van Hooff M, Vermetten E, Vinkers CH, Voisey J, Wang Y, Wang Z, Werge T, Williams MA, Williamson DE, Winternitz S, Wolf C, Wolf EJ, Wolff JD, Yehuda R, Young RM, Young KA, Zhao H, Zoellner LA, Liberzon I, Ressler KJ, Haas M, Koenen KC. PMID: 31594949.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    9. Assessing Neuronal and Astrocyte Derived Exosomes From Individuals With Mild Traumatic Brain Injury for Markers of Neurodegeneration and Cytotoxic Activity. Front Neurosci. 2019; 13:1005. Winston CN, Romero HK, Ellisman M, Nauss S, Julovich DA, Conger T, Hall JR, Campana W, O'Bryant SE, Nievergelt CM, Baker DG, Risbrough VB, Rissman RA. PMID: 31680797.
      View in: PubMed   Mentions:
    10. Localization of amyloid beta peptides to locus coeruleus and medial prefrontal cortex in corticotropin releasing factor overexpressing male and female mice. Brain Struct Funct. 2019 Sep; 224(7):2385-2405. Ross JA, Alexis R, Reyes BAS, Risbrough V, Van Bockstaele EJ. PMID: 31250157.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    11. Characterizing the neural circuitry associated with configural threat learning. Brain Res. 2019 09 15; 1719:225-234. Stout DM, Glenn DE, Acheson DT, Simmons AN, Risbrough VB. PMID: 31173725.
      View in: PubMed   Mentions:    Fields:    
    12. Common pathways and communication between the brain and heart: connecting post-traumatic stress disorder and heart failure. Stress. 2019 09; 22(5):530-547. Wilson MA, Liberzon I, Lindsey ML, Lokshina Y, Risbrough VB, Sah R, Wood SK, Williamson JB, Spinale FG. PMID: 31161843.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. Heritable Differences in Catecholamine Signaling Modulate Susceptibility to Trauma and Response to Methylphenidate Treatment: Relevance for PTSD. Front Behav Neurosci. 2019; 13:111. Deslauriers J, Toth M, Zhou X, Risbrough VB. PMID: 31164811.
      View in: PubMed   Mentions:
    14. MEG Working Memory N-Back Task Reveals Functional Deficits in Combat-Related Mild Traumatic Brain Injury. Cereb Cortex. 2019 05 01; 29(5):1953-1968. Huang MX, Nichols S, Robb-Swan A, Angeles-Quinto A, Harrington DL, Drake A, Huang CW, Song T, Diwakar M, Risbrough VB, Matthews S, Clifford R, Cheng CK, Huang JW, Sinha A, Yurgil KA, Ji Z, Lerman I, Lee RR, Baker DG. PMID: 29668852.
      View in: PubMed   Mentions: 1     Fields:    
    15. Kainate receptor auxiliary subunit NETO2 is required for normal fear expression and extinction. Neuropsychopharmacology. 2019 10; 44(11):1855-1866. Mennesson M, Rydgren E, Lipina T, Sokolowska E, Kulesskaya N, Morello F, Ivakine E, Voikar V, Risbrough V, Partanen J, Hovatta I. PMID: 30770891.
      View in: PubMed   Mentions: 2     Fields:    
    16. Aversive distractors modulate affective working memory in frontoparietal regions. Emotion. 2020 Mar; 20(2):286-295. Stout DM, Bomyea J, Risbrough VB, Simmons AN. PMID: 30570314.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    17. Measuring novel antecedents of mental illness: the Questionnaire of Unpredictability in Childhood. Neuropsychopharmacology. 2019 04; 44(5):876-882. Glynn LM, Stern HS, Howland MA, Risbrough VB, Baker DG, Nievergelt CM, Baram TZ, Davis EP. PMID: 30470840.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    18. Heart rate variability and emotion regulation among individuals with obesity and loss of control eating. Physiol Behav. 2019 02 01; 199:73-78. Godfrey KM, Juarascio A, Manasse S, Minassian A, Risbrough V, Afari N. PMID: 30414883.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    19. Multimodal canonical correlation reveals converging neural circuitry across trauma-related disorders of affect and cognition. Neurobiol Stress. 2018 Nov; 9:241-250. Stout DM, Buchsbaum MS, Spadoni AD, Risbrough VB, Strigo IA, Matthews SC, Simmons AN. PMID: 30450388.
      View in: PubMed   Mentions:
    20. REM sleep and safety signal learning in posttraumatic stress disorder: A preliminary study in military veterans. Neurobiol Stress. 2018 Nov; 9:22-28. Straus LD, Norman SB, Risbrough VB, Acheson DT, Drummond SPA. PMID: 30116769.
      View in: PubMed   Mentions:
    21. Neural measures associated with configural threat acquisition. Neurobiol Learn Mem. 2018 04; 150:99-106. Stout DM, Glenn DE, Acheson DT, Spadoni AD, Risbrough VB, Simmons AN. PMID: 29544725.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    22. The Relationship Between Chronic Pain and Neurocognitive Function: A Systematic Review. Clin J Pain. 2018 03; 34(3):262-275. Higgins DM, Martin AM, Baker DG, Vasterling JJ, Risbrough V. PMID: 28719507.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    23. A signal detection-item response theory model for evaluating neuropsychological measures. J Clin Exp Neuropsychol. 2018 10; 40(8):745-760. Thomas ML, Brown GG, Gur RC, Moore TM, Patt VM, Risbrough VB, Baker DG. PMID: 29402152.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    24. Individual variation in working memory is associated with fear extinction performance. Behav Res Ther. 2018 03; 102:52-59. Stout DM, Acheson DT, Moore TM, Gur RC, Baker DG, Geyer MA, Risbrough VB. PMID: 29331727.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    25. The Future of Contextual Fear Learning for PTSD Research: A Methodological Review of Neuroimaging Studies. Curr Top Behav Neurosci. 2018; 38:207-228. Glenn DE, Risbrough VB, Simmons AN, Acheson DT, Stout DM. PMID: 29063483.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    26. Sleep Disruption, Safety Learning, and Fear Extinction in Humans: Implications for Posttraumatic Stress Disorder. Curr Top Behav Neurosci. 2018; 38:193-205. Straus LD, Drummond SPA, Risbrough VB, Norman SB. PMID: 28942597.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    27. Does Anhedonia Presage Increased Risk of Posttraumatic Stress Disorder? : Adolescent Anhedonia and Posttraumatic Disorders. Curr Top Behav Neurosci. 2018; 38:249-265. Risbrough VB, Glynn LM, Davis EP, Sandman CA, Obenaus A, Stern HS, Keator DB, Yassa MA, Baram TZ, Baker DG. PMID: 29796839.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    28. Traumatic stress and accelerated DNA methylation age: A meta-analysis. Psychoneuroendocrinology. 2018 06; 92:123-134. Wolf EJ, Maniates H, Nugent N, Maihofer AX, Armstrong D, Ratanatharathorn A, Ashley-Koch AE, Garrett M, Kimbrel NA, Lori A, Aiello AE, Baker DG, Beckham JC, Boks MP, Galea S, Geuze E, Hauser MA, Kessler RC, Koenen KC, Miller MW, Ressler KJ, Risbrough V, Rutten BPF, Stein MB, Ursano RJ, Vermetten E, Vinkers CH, Uddin M, Smith AK, Nievergelt CM, Logue MW. PMID: 29452766.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    29. Current Status of Animal Models of Posttraumatic Stress Disorder: Behavioral and Biological Phenotypes, and Future Challenges in Improving Translation. Biol Psychiatry. 2018 05 15; 83(10):895-907. Deslauriers J, Toth M, Der-Avakian A, Risbrough VB. PMID: 29338843.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansAnimals
    30. PTSD Blood Transcriptome Mega-Analysis: Shared Inflammatory Pathways across Biological Sex and Modes of Trauma. Neuropsychopharmacology. 2018 02; 43(3):469-481. Breen MS, Tylee DS, Maihofer AX, Neylan TC, Mehta D, Binder EB, Chandler SD, Hess JL, Kremen WS, Risbrough VB, Woelk CH, Baker DG, Nievergelt CM, Tsuang MT, Buxbaum JD, Glatt SJ. PMID: 28925389.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    31. Inhibition of p75 neurotrophin receptor does not rescue cognitive impairment in adulthood after isoflurane exposure in neonatal mice. Br J Anaesth. 2017 Sep 01; 119(3):465-471. Schilling JM, Kassan A, Mandyam C, Pearn ML, Voong A, Grogman GG, Risbrough VB, Niesman IR, Patel HH, Patel PM, Head BP. PMID: 28969308.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    32. Effects of military service and deployment on clinical symptomatology: The role of trauma exposure and social support. J Psychiatr Res. 2017 12; 95:121-128. Moore TM, Risbrough VB, Baker DG, Larson GE, Glenn DE, Nievergelt CM, Maihofer A, Port AM, Jackson CT, Ruparel K, Gur RC. PMID: 28843074.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    33. COMT val158met polymorphism links to altered fear conditioning and extinction are modulated by PTSD and childhood trauma. Depress Anxiety. 2018 01; 35(1):32-42. Deslauriers J, Acheson DT, Maihofer AX, Nievergelt CM, Baker DG, Geyer MA, Risbrough VB. PMID: 28833952.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    34. Erratum: Genetic loci associated with heart rate variability and their effects on cardiac disease risk. Nat Commun. 2017 08 02; 8:16140. Nolte IM, Munoz ML, Tragante V, Amare AT, Jansen R, Vaez A, von der Heyde B, Avery CL, Bis JC, Dierckx B, van Dongen J, Gogarten SM, Goyette P, Hernesniemi J, Huikari V, Hwang SJ, Jaju D, Kerr KF, Kluttig A, Krijthe BP, Kumar J, van der Laan SW, Lyytikäinen LP, Maihofer AX, Minassian A, van der Most PJ, Müller-Nurasyid M, Nivard M, Salvi E, Stewart JD, Thayer JF, Verweij N, Wong A, Zabaneh D, Zafarmand MH, Abdellaoui A, Albarwani S, Albert C, Alonso A, Ashar F, Auvinen J, Axelsson T, Baker DG, de Bakker PIW, Barcella M, Bayoumi R, Bieringa RJ, Boomsma D, Boucher G, Britton AR, Christophersen I, Dietrich A, Ehret GB, Ellinor PT, Eskola M, Felix JF, Floras JS, Franco OH, Friberg P, Gademan MGJ, Geyer MA, Giedraitis V, Hartman CA, Hemerich D, Hofman A, Hottenga JJ, Huikuri H, Hutri-Kähönen N, Jouven X, Junttila J, Juonala M, Kiviniemi AM, Kors JA, Kumari M, Kuznetsova T, Laurie CC, Lefrandt JD, Li Y, Li Y, Liao D, Limacher MC, Lin HJ, Lindgren CM, Lubitz SA, Mahajan A, McKnight B, Zu Schwabedissen HM, Milaneschi Y, Mononen N, Morris AP, Nalls MA, Navis G, Neijts M, Nikus K, North KE, O'Connor DT, Ormel J, Perz S, Peters A, Psaty BM, Raitakari OT, Risbrough VB, Sinner MF, Siscovick D, Smit JH, Smith NL, Soliman EZ, Sotoodehnia N, Staessen JA, Stein PK, Stilp AM, Stolarz-Skrzypek K, Strauch K, Sundström J, Swenne CA, Syvänen AC, Tardif JC, Taylor KD, Teumer A, Thornton TA, Tinker LE, Uitterlinden AG, van Setten J, Voss A, Waldenberger M, Wilhelmsen KC, Willemsen G, Wong Q, Zhang ZM, Zonderman AB, Cusi D, Evans MK, Greiser HK, van der Harst P, Hassan M, Ingelsson E, Järvelin MR, Kääb S, Kähönen M, Kivimaki M, Kooperberg C, Kuh D, Lehtimäki T, Lind L, Nievergelt CM, O'Donnell CJ, Oldehinkel AJ, Penninx B, Reiner AP, Riese H, van Roon AM, Rioux JD, Rotter JI, Sofer T, Stricker BH, Tiemeier H, Vrijkotte TGM, Asselbergs FW, Brundel BJJM, Heckbert SR, Whitsel EA, den Hoed M, Snieder H, de Geus EJC. PMID: 28767105.
      View in: PubMed   Mentions: 1     Fields:    
    35. Genetic loci associated with heart rate variability and their effects on cardiac disease risk. Nat Commun. 2017 06 14; 8:15805. Nolte IM, Munoz ML, Tragante V, Amare AT, Jansen R, Vaez A, von der Heyde B, Avery CL, Bis JC, Dierckx B, van Dongen J, Gogarten SM, Goyette P, Hernesniemi J, Huikari V, Hwang SJ, Jaju D, Kerr KF, Kluttig A, Krijthe BP, Kumar J, van der Laan SW, Lyytikäinen LP, Maihofer AX, Minassian A, van der Most PJ, Müller-Nurasyid M, Nivard M, Salvi E, Stewart JD, Thayer JF, Verweij N, Wong A, Zabaneh D, Zafarmand MH, Abdellaoui A, Albarwani S, Albert C, Alonso A, Ashar F, Auvinen J, Axelsson T, Baker DG, de Bakker PIW, Barcella M, Bayoumi R, Bieringa RJ, Boomsma D, Boucher G, Britton AR, Christophersen I, Dietrich A, Ehret GB, Ellinor PT, Eskola M, Felix JF, Floras JS, Franco OH, Friberg P, Gademan MGJ, Geyer MA, Giedraitis V, Hartman CA, Hemerich D, Hofman A, Hottenga JJ, Huikuri H, Hutri-Kähönen N, Jouven X, Junttila J, Juonala M, Kiviniemi AM, Kors JA, Kumari M, Kuznetsova T, Laurie CC, Lefrandt JD, Li Y, Li Y, Liao D, Limacher MC, Lin HJ, Lindgren CM, Lubitz SA, Mahajan A, McKnight B, Zu Schwabedissen HM, Milaneschi Y, Mononen N, Morris AP, Nalls MA, Navis G, Neijts M, Nikus K, North KE, O'Connor DT, Ormel J, Perz S, Peters A, Psaty BM, Raitakari OT, Risbrough VB, Sinner MF, Siscovick D, Smit JH, Smith NL, Soliman EZ, Sotoodehnia N, Staessen JA, Stein PK, Stilp AM, Stolarz-Skrzypek K, Strauch K, Sundström J, Swenne CA, Syvänen AC, Tardif JC, Taylor KD, Teumer A, Thornton TA, Tinker LE, Uitterlinden AG, van Setten J, Voss A, Waldenberger M, Wilhelmsen KC, Willemsen G, Wong Q, Zhang ZM, Zonderman AB, Cusi D, Evans MK, Greiser HK, van der Harst P, Hassan M, Ingelsson E, Järvelin MR, Kääb S, Kähönen M, Kivimaki M, Kooperberg C, Kuh D, Lehtimäki T, Lind L, Nievergelt CM, O'Donnell CJ, Oldehinkel AJ, Penninx B, Reiner AP, Riese H, van Roon AM, Rioux JD, Rotter JI, Sofer T, Stricker BH, Tiemeier H, Vrijkotte TGM, Asselbergs FW, Brundel BJJM, Heckbert SR, Whitsel EA, den Hoed M, Snieder H, de Geus EJC. PMID: 28613276.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    36. Fear learning alterations after traumatic brain injury and their role in development of posttraumatic stress symptoms. Depress Anxiety. 2017 08; 34(8):723-733. Glenn DE, Acheson DT, Geyer MA, Nievergelt CM, Baker DG, Risbrough VB. PMID: 28489272.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    37. Immune signaling mechanisms of PTSD risk and symptom development: insights from animal models. Curr Opin Behav Sci. 2017 Apr; 14:123-132. Deslauriers J, Powell S, Risbrough VB. PMID: 28758144.
      View in: PubMed   Mentions:
    38. Sleep Deprivation Disrupts Recall of Conditioned Fear Extinction. Biol Psychiatry Cogn Neurosci Neuroimaging. 2017 Mar; 2(2):123-129. Straus LD, Acheson DT, Risbrough VB, Drummond SPA. PMID: 28758152.
      View in: PubMed   Mentions: 8     Fields:    
    39. Effects of LPS-induced immune activation prior to trauma exposure on PTSD-like symptoms in mice. Behav Brain Res. 2017 04 14; 323:117-123. Deslauriers J, van Wijngaarde M, Geyer MA, Powell S, Risbrough VB. PMID: 28159589.
      View in: PubMed   Mentions: 1     Fields:    Translation:Animals
    40. Resting-State Magnetoencephalography Reveals Different Patterns of Aberrant Functional Connectivity in Combat-Related Mild Traumatic Brain Injury. J Neurotrauma. 2017 04 01; 34(7):1412-1426. Huang MX, Harrington DL, Robb Swan A, Angeles Quinto A, Nichols S, Drake A, Song T, Diwakar M, Huang CW, Risbrough VB, Dale A, Bartsch H, Matthews S, Huang JW, Lee RR, Baker DG. PMID: 27762653.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    41. Prepulse Inhibition Deficits in Obsessive-Compulsive Disorder are More Pronounced in Females. Neuropsychopharmacology. 2016 12; 41(13):2963-2964. Ahmari SE, Risbrough VB, Geyer MA, Simpson HB. PMID: 27818517.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    42. PREPULSE INHIBITION DEFICITS ONLY IN FEMALES WITH OBSESSIVE-COMPULSIVE DISORDER. Depress Anxiety. 2016 Mar; 33(3):238-46. Steinman SA, Ahmari SE, Choo T, Kimeldorf MB, Feit R, Loh S, Risbrough V, Geyer MA, Steinglass JE, Wall M, Schneier FR, Fyer AJ, Simpson HB. PMID: 26878422.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    43. HIGH AND LOW THRESHOLD FOR STARTLE REACTIVITY ASSOCIATED WITH PTSD SYMPTOMS BUT NOT PTSD RISK: EVIDENCE FROM A PROSPECTIVE STUDY OF ACTIVE DUTY MARINES. Depress Anxiety. 2016 Mar; 33(3):192-202. Glenn DE, Acheson DT, Geyer MA, Nievergelt CM, Baker DG, Risbrough VB. PMID: 26878585.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    44. Heart Rate Variability and Posttraumatic Stress Disorder. JAMA Psychiatry. 2016 Feb; 73(2):178-9. Minassian A, Baker DG, Risbrough VB. PMID: 26720754.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    45. Prospective Associations Between Traumatic Brain Injury and Postdeployment Tinnitus in Active-Duty Marines. J Head Trauma Rehabil. 2016 Jan-Feb; 31(1):30-9. Yurgil KA, Clifford RE, Risbrough VB, Geyer MA, Huang M, Barkauskas DA, Vasterling JJ, Baker DG. PMID: 25699623.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    46. On the Road to Translation for PTSD Treatment: Theoretical and Practical Considerations of the Use of Human Models of Conditioned Fear for Drug Development. Curr Top Behav Neurosci. 2016; 28:173-96. Risbrough VB, Glenn DE, Baker DG. PMID: 27311760.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    47. Overexpression of Forebrain CRH During Early Life Increases Trauma Susceptibility in Adulthood. Neuropsychopharmacology. 2016 May; 41(6):1681-90. Toth M, Flandreau EI, Deslauriers J, Geyer MA, Mansuy IM, Merlo Pich E, Risbrough VB. PMID: 26538448.
      View in: PubMed   Mentions: 5     Fields:    Translation:Animals
    48. Neuron-Targeted Caveolin-1 Improves Molecular Signaling, Plasticity, and Behavior Dependent on the Hippocampus in Adult and Aged Mice. Biol Psychiatry. 2017 01 15; 81(2):101-110. Mandyam CD, Schilling JM, Cui W, Egawa J, Niesman IR, Kellerhals SE, Staples MC, Busija AR, Risbrough VB, Posadas E, Grogman GC, Chang JW, Roth DM, Patel PM, Patel HH, Head BP. PMID: 26592463.
      View in: PubMed   Mentions: 12     Fields:    Translation:AnimalsCells
    49. Association of Predeployment Heart Rate Variability With Risk of Postdeployment Posttraumatic Stress Disorder in Active-Duty Marines. JAMA Psychiatry. 2015 Oct; 72(10):979-86. Minassian A, Maihofer AX, Baker DG, Nievergelt CM, Geyer MA, Risbrough VB. PMID: 26353072.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    50. Oxytocin enhancement of fear extinction: a new target for facilitating exposure-based treatments? Biol Psychiatry. 2015 Aug 01; 78(3):154-5. Acheson DT, Risbrough VB. PMID: 26143973.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    51. Fear extinction memory performance in a sample of stable, euthymic patients with bipolar disorder. J Affect Disord. 2015 Oct 01; 185:230-8. Acheson DT, Eyler LT, Resovsky J, Tsan E, Risbrough VB. PMID: 26247493.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    52. Restoration of Sp4 in Forebrain GABAergic Neurons Rescues Hypersensitivity to Ketamine in Sp4 Hypomorphic Mice. Int J Neuropsychopharmacol. 2015 Jun 02; 18(11):pyv063. Higa KK, Ji B, Buell MR, Risbrough VB, Powell SB, Young JW, Geyer MA, Zhou X. PMID: 26037489.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    53. The GABA(B) receptor positive modulator BHF177 attenuated anxiety, but not conditioned fear, in rats. Neuropharmacology. 2015 Oct; 97:357-64. Li X, Kaczanowska K, Finn MG, Markou A, Risbrough VB. PMID: 26002628.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    54. Maximizing the utility of a single site randomized controlled psychotherapy trial. Contemp Clin Trials. 2015 May; 42:244-51. Norman SB, Haller M, Spadoni AD, Drummond SP, Risbrough V, Hamblen JL, Trim RS, Blanes EX. PMID: 25933919.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    55. Intranasal oxytocin administration prior to exposure therapy for arachnophobia impedes treatment response. Depress Anxiety. 2015 Jun; 32(6):400-7. Acheson DT, Feifel D, Kamenski M, Mckinney R, Risbrough VB. PMID: 25826649.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimals
    56. Gene networks specific for innate immunity define post-traumatic stress disorder. Mol Psychiatry. 2015 Dec; 20(12):1538-45. Breen MS, Maihofer AX, Glatt SJ, Tylee DS, Chandler SD, Tsuang MT, Risbrough VB, Baker DG, O'Connor DT, Nievergelt CM, Woelk CH. PMID: 25754082.
      View in: PubMed   Mentions: 34     Fields:    Translation:Humans
    57. Pavlovian conditioning to hedonic food cues in overweight and lean individuals. Appetite. 2015 Apr; 87:56-61. Meyer MD, Risbrough VB, Liang J, Boutelle KN. PMID: 25526826.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsCTClinical Trials
    58. Cell type-specific modifications of corticotropin-releasing factor (CRF) and its type 1 receptor (CRF1) on startle behavior and sensorimotor gating. Psychoneuroendocrinology. 2015 Mar; 53:16-28. Flandreau E, Risbrough V, Lu A, Ableitner M, Geyer MA, Holsboer F, Deussing JM. PMID: 25575243.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    59. Design and implementation of a study evaluating extinction processes to food cues in obese children: the Intervention for Regulations of Cues Trial (iROC). Contemp Clin Trials. 2015 Jan; 40:95-104. Boutelle KN, Liang J, Knatz S, Matheson B, Risbrough V, Strong D, Rhee KE, Craske MG, Zucker N, Bouton ME. PMID: 25461494.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCTClinical Trials
    60. Genomic predictors of combat stress vulnerability and resilience in U.S. Marines: A genome-wide association study across multiple ancestries implicates PRTFDC1 as a potential PTSD gene. Psychoneuroendocrinology. 2015 Jan; 51:459-71. Nievergelt CM, Maihofer AX, Mustapic M, Yurgil KA, Schork NJ, Miller MW, Logue MW, Geyer MA, Risbrough VB, O'Connor DT, Baker DG. PMID: 25456346.
      View in: PubMed   Mentions: 43     Fields:    Translation:Humans
    61. Conditioned fear and extinction learning performance and its association with psychiatric symptoms in active duty Marines. Psychoneuroendocrinology. 2015 Jan; 51:495-505. Acheson DT, Geyer MA, Baker DG, Nievergelt CM, Yurgil K, Risbrough VB. PMID: 25444643.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    62. Fear conditioning, safety learning, and sleep in humans. J Neurosci. 2014 Aug 27; 34(35):11754-60. Marshall AJ, Acheson DT, Risbrough VB, Straus LD, Drummond SP. PMID: 25164670.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    63. Voxel-wise resting-state MEG source magnitude imaging study reveals neurocircuitry abnormality in active-duty service members and veterans with PTSD. Neuroimage Clin. 2014; 5:408-19. Huang MX, Yurgil KA, Robb A, Angeles A, Diwakar M, Risbrough VB, Nichols SL, McLay R, Theilmann RJ, Song T, Huang CW, Lee RR, Baker DG. PMID: 25180160.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    64. Reversal of autism-like behaviors and metabolism in adult mice with single-dose antipurinergic therapy. Transl Psychiatry. 2014 Jun 17; 4:e400. Naviaux JC, Schuchbauer MA, Li K, Wang L, Risbrough VB, Powell SB, Naviaux RK. PMID: 24937094.
      View in: PubMed   Mentions: 33     Fields:    Translation:Animals
    65. Single-subject-based whole-brain MEG slow-wave imaging approach for detecting abnormality in patients with mild traumatic brain injury. Neuroimage Clin. 2014; 5:109-19. Huang MX, Nichols S, Baker DG, Robb A, Angeles A, Yurgil KA, Drake A, Levy M, Song T, McLay R, Theilmann RJ, Diwakar M, Risbrough VB, Ji Z, Huang CW, Chang DG, Harrington DL, Muzzatti L, Canive JM, Christopher Edgar J, Chen YH, Lee RR. PMID: 25009772.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    66. Heart rate variability characteristics in a large group of active-duty marines and relationship to posttraumatic stress. Psychosom Med. 2014 May; 76(4):292-301. Minassian A, Geyer MA, Baker DG, Nievergelt CM, O'Connor DT, Risbrough VB. PMID: 24804881.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    67. Long-term atorvastatin treatment leads to alterations in behavior, cognition, and hippocampal biochemistry. Behav Brain Res. 2014 Jul 01; 267:6-11. Schilling JM, Cui W, Godoy JC, Risbrough VB, Niesman IR, Roth DM, Patel PM, Drummond JC, Patel HH, Zemljic-Harpf AE, Head BP. PMID: 24657594.
      View in: PubMed   Mentions: 8     Fields:    Translation:Animals
    68. Generation and characterization of humanized mice carrying COMT158 Met/Val alleles. Neuropsychopharmacology. 2014 Jul; 39(8):1823-32. Risbrough V, Ji B, Hauger R, Zhou X. PMID: 24509724.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimals
    69. Psychophysiology in the study of psychological trauma: where are we now and where do we need to be? Curr Top Behav Neurosci. 2014; 21:157-83. Acheson DT, Geyer MA, Risbrough VB. PMID: 25158622.
      View in: PubMed   Mentions: 2     Fields:    
    70. Inhibition of phosphodiesterase 10A has differential effects on dopamine D1 and D2 receptor modulation of sensorimotor gating. Psychopharmacology (Berl). 2014 May; 231(10):2189-97. Gresack JE, Seymour PA, Schmidt CJ, Risbrough VB. PMID: 24363077.
      View in: PubMed   Mentions: 8     Fields:    Translation:AnimalsCells
    71. Sleep deprivation impairs performance in the 5-choice continuous performance test: similarities between humans and mice. Behav Brain Res. 2014 Mar 15; 261:40-8. van Enkhuizen J, Acheson D, Risbrough V, Drummond S, Geyer MA, Young JW. PMID: 24333377.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansAnimals
    72. Forebrain-specific CRF overproduction during development is sufficient to induce enduring anxiety and startle abnormalities in adult mice. Neuropsychopharmacology. 2014 May; 39(6):1409-19. Toth M, Gresack JE, Bangasser DA, Plona Z, Valentino RJ, Flandreau EI, Mansuy IM, Merlo-Pich E, Geyer MA, Risbrough VB. PMID: 24326400.
      View in: PubMed   Mentions: 12     Fields:    Translation:Animals
    73. The role of PKC signaling in CRF-induced modulation of startle. Psychopharmacology (Berl). 2013 Oct; 229(4):579-89. Toth M, Gresack JE, Hauger RL, Halberstadt AL, Risbrough VB. PMID: 23722830.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    74. The effect of intranasal oxytocin treatment on conditioned fear extinction and recall in a healthy human sample. Psychopharmacology (Berl). 2013 Sep; 229(1):199-208. Acheson D, Feifel D, de Wilde S, McKinney R, Lohr J, Risbrough V. PMID: 23644911.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    75. The ameliorating effects of 5,7-dihydroxy-6-methoxy-2(4-phenoxyphenyl)-4H-chromene-4-one, an oroxylin A derivative, against memory impairment and sensorimotor gating deficit in mice. Arch Pharm Res. 2013 Jul; 36(7):854-63. Liu X, Hong SI, Park SJ, Dela Peña JB, Che H, Yoon SY, Kim DH, Kim JM, Cai M, Risbrough V, Geyer MA, Shin CY, Cheong JH, Park H, Lew JH, Ryu JH. PMID: 23543630.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    76. Short-term recognition memory correlates with regional CNS expression of microRNA-138 in mice. Am J Geriatr Psychiatry. 2013 May; 21(5):461-73. Tatro ET, Risbrough V, Soontornniyomkij B, Young J, Shumaker-Armstrong S, Jeste DV, Achim CL. PMID: 23570889.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    77. Impaired conditioned fear response and startle reactivity in epinephrine-deficient mice. Behav Pharmacol. 2013 Feb; 24(1):1-9. Toth M, Ziegler M, Sun P, Gresack J, Risbrough V. PMID: 23268986.
      View in: PubMed   Mentions: 9     Fields:    Translation:AnimalsCells
    78. Comparison of the effects of the GABAB receptor positive modulator BHF177 and the GABAB receptor agonist baclofen on anxiety-like behavior, learning, and memory in mice. Neuropharmacology. 2013 Jul; 70:156-67. Li X, Risbrough VB, Cates-Gatto C, Kaczanowska K, Finn MG, Roberts AJ, Markou A. PMID: 23376712.
      View in: PubMed   Mentions: 11     Fields:    Translation:Animals
    79. A consideration of select pre-trauma factors as key vulnerabilities in PTSD. Clin Psychol Rev. 2012 Nov; 32(7):630-41. Bomyea J, Risbrough V, Lang AJ. PMID: 22917742.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    80. Effects of anxiolytic treatment on potentiated startle during aversive image anticipation. Hum Psychopharmacol. 2012 Jul; 27(4):419-27. Acheson DT, Stein MB, Paulus MP, Ravindran L, Simmons AN, Lohr JB, Risbrough VB. PMID: 22782542.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    81. Predictors of risk and resilience for posttraumatic stress disorder among ground combat Marines: methods of the Marine Resiliency Study. Prev Chronic Dis. 2012; 9:E97. Baker DG, Nash WP, Litz BT, Geyer MA, Risbrough VB, Nievergelt CM, O'Connor DT, Larson GE, Schork NJ, Vasterling JJ, Hammer PS, Webb-Murphy JA. PMID: 22575082.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    82. The effect of pregabalin on sensorimotor gating in 'low' gating humans and mice. Neuropharmacology. 2012 Sep; 63(3):480-5. Acheson DT, Stein MB, Paulus MP, Geyer MA, Risbrough VB. PMID: 22575075.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimals
    83. Hippocampal calbindin-1 immunoreactivity correlate of recognition memory performance in aged mice. Neurosci Lett. 2012 May 10; 516(1):161-5. Soontornniyomkij V, Risbrough VB, Young JW, Soontornniyomkij B, Jeste DV, Achim CL. PMID: 22503902.
      View in: PubMed   Mentions: 10     Fields:    Translation:AnimalsCells
    84. Decreased startle modulation during anticipation in the postpartum period in comparison to late pregnancy. Arch Womens Ment Health. 2012 Apr; 15(2):87-94. Hellgren C, Bannbers E, Åkerud H, Risbrough V, Poromaa IS. PMID: 22315106.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    85. Impaired sensorimotor gating in unmedicated adults with obsessive-compulsive disorder. Neuropsychopharmacology. 2012 Apr; 37(5):1216-23. Ahmari SE, Risbrough VB, Geyer MA, Simpson HB. PMID: 22218093.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    86. Neuropharmacology special issue on posttraumatic stress disorder (PTSD): current state of the art in clinical and preclinical PTSD research. Neuropharmacology. 2012 Feb; 62(2):539-41. Risbrough VB, Stein MB. PMID: 21875608.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    87. Factor analysis of attentional set-shifting performance in young and aged mice. Behav Brain Funct. 2011 Aug 12; 7:33. Tanaka S, Young JW, Gresack JE, Geyer MA, Risbrough VB. PMID: 21838910.
      View in: PubMed   Mentions: 3     Fields:    Translation:Animals
    88. Pharmacological treatment of PTSD - established and new approaches. Neuropharmacology. 2012 Feb; 62(2):617-27. Steckler T, Risbrough V. PMID: 21736888.
      View in: PubMed   Mentions: 51     Fields:    Translation:Humans
    89. Hippocampal dysfunction effects on context memory: possible etiology for posttraumatic stress disorder. Neuropharmacology. 2012 Feb; 62(2):674-85. Acheson DT, Gresack JE, Risbrough VB. PMID: 21596050.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    90. Enhanced effects of amphetamine but reduced effects of the hallucinogen, 5-MeO-DMT, on locomotor activity in 5-HT(1A) receptor knockout mice: implications for schizophrenia. Neuropharmacology. 2011 Jul-Aug; 61(1-2):209-16. van den Buuse M, Ruimschotel E, Martin S, Risbrough VB, Halberstadt AL. PMID: 21501627.
      View in: PubMed   Mentions: 11     Fields:    Translation:Animals
    91. Patients with premenstrual dysphoric disorder have increased startle modulation during anticipation in the late luteal phase period in comparison to control subjects. Psychoneuroendocrinology. 2011 Sep; 36(8):1184-92. Bannbers E, Kask K, Wikström J, Risbrough V, Poromaa IS. PMID: 21435793.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    92. Increased hippocampal accumulation of autophagosomes predicts short-term recognition memory impairment in aged mice. Age (Dordr). 2012 Apr; 34(2):305-16. Soontornniyomkij V, Risbrough VB, Young JW, Soontornniyomkij B, Jeste DV, Achim CL. PMID: 21431350.
      View in: PubMed   Mentions: 9     Fields:    Translation:AnimalsCells
    93. Disruption of prepulse inhibition by 3,4-methylenedioxymethamphetamine (MDMA): comparison between male and female wild-type and 5-HT(1A) receptor knockout mice. Int J Neuropsychopharmacol. 2011 Jul; 14(6):856-61. van den Buuse M, Becker T, Kwek P, Martin S, Ruimschotel E, Risbrough V. PMID: 21329554.
      View in: PubMed   Mentions: 7     Fields:    Translation:Animals
    94. Corticotropin-releasing factor and noradrenergic signalling exert reciprocal control over startle reactivity. Int J Neuropsychopharmacol. 2011 Oct; 14(9):1179-94. Gresack JE, Risbrough VB. PMID: 21205416.
      View in: PubMed   Mentions: 14     Fields:    Translation:AnimalsCells
    95. Initial evidence linking synaptic superoxide production with poor short-term memory in aged mice. Brain Res. 2011 Jan 12; 1368:65-70. Ali SS, Young JW, Wallace CK, Gresack J, Jeste DV, Geyer MA, Dugan LL, Risbrough VB. PMID: 21075081.
      View in: PubMed   Mentions: 11     Fields:    Translation:AnimalsCells
    96. The effects of globin on microarray-based gene expression analysis of mouse blood. Mamm Genome. 2010 Jun; 21(5-6):268-75. Winn ME, Zapala MA, Hovatta I, Risbrough VB, Lillie E, Schork NJ. PMID: 20473674.
      View in: PubMed   Mentions: 4     Fields:    Translation:Animals
    97. CRF2 null mutation increases sensitivity to isolation rearing effects on locomotor activity in mice. Neuropeptides. 2010 Aug; 44(4):349-53. Gresack J, Powell S, Geyer M, Poore MS, Coste S, Risbrough V. PMID: 20466421.
      View in: PubMed   Mentions: 4     Fields:    Translation:Animals
    98. The mouse attentional-set-shifting task: a method for assaying successful cognitive aging? Cogn Affect Behav Neurosci. 2010 May; 10(2):243-51. Young JW, Powell SB, Geyer MA, Jeste DV, Risbrough VB. PMID: 20498348.
      View in: PubMed   Mentions: 31     Fields:    Translation:Animals
    99. Short-term recognition memory impairment is associated with decreased expression of FK506 binding protein 51 in the aged mouse brain. Age (Dordr). 2010 Sep; 32(3):309-22. Soontornniyomkij V, Risbrough VB, Young JW, Wallace CK, Soontornniyomkij B, Jeste DV, Achim CL. PMID: 20422297.
      View in: PubMed   Mentions: 20     Fields:    Translation:AnimalsCells
    100. Age-associated improvements in cross-modal prepulse inhibition in mice. Behav Neurosci. 2010 Feb; 124(1):133-140. Young JW, Wallace CK, Geyer MA, Risbrough VB. PMID: 20141288.
      View in: PubMed   Mentions: 11     Fields:    Translation:Animals
    101. Isolation rearing-induced deficits in contextual fear learning do not require CRF(2) receptors. Behav Brain Res. 2010 May 01; 209(1):80-4. Gresack JE, Risbrough VB, Scott CN, Coste S, Stenzel-Poore M, Geyer MA, Powell SB. PMID: 20097235.
      View in: PubMed   Mentions: 16     Fields:    Translation:Animals
    102. Behavioral correlates of anxiety. Curr Top Behav Neurosci. 2010; 2:205-28. Risbrough V. PMID: 21309111.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    103. Role of CRF receptor signaling in stress vulnerability, anxiety, and depression. Ann N Y Acad Sci. 2009 Oct; 1179:120-43. Hauger RL, Risbrough V, Oakley RH, Olivares-Reyes JA, Dautzenberg FM. PMID: 19906236.
      View in: PubMed   Mentions: 82     Fields:    Translation:HumansCells
    104. CRF receptor blockade prevents initiation and consolidation of stress effects on affect in the predator stress model of PTSD. Int J Neuropsychopharmacol. 2010 Jul; 13(6):747-57. Adamec R, Fougere D, Risbrough V. PMID: 19751543.
      View in: PubMed   Mentions: 21     Fields:    Translation:Animals
    105. Post-traumatic stress disorder: emerging concepts of pharmacotherapy. Expert Opin Emerg Drugs. 2009 Jun; 14(2):251-72. Baker DG, Nievergelt CM, Risbrough VB. PMID: 19453285.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimals
    106. 5-HT1A receptor activation is necessary for 5-MeODMT-dependent potentiation of feeding inhibition. Pharmacol Biochem Behav. 2009 Sep; 93(3):349-53. Duvvuri V, Risbrough VB, Kaye WH, Geyer MA. PMID: 19490926.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    107. 5-HT(2A) and 5-HT(2C) receptors exert opposing effects on locomotor activity in mice. Neuropsychopharmacology. 2009 Jul; 34(8):1958-67. Halberstadt AL, van der Heijden I, Ruderman MA, Risbrough VB, Gingrich JA, Geyer MA, Powell SB. PMID: 19322172.
      View in: PubMed   Mentions: 51     Fields:    Translation:AnimalsCells
    108. Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia. Pharmacol Ther. 2009 May; 122(2):150-202. Young JW, Powell SB, Risbrough V, Marston HM, Geyer MA. PMID: 19269307.
      View in: PubMed   Mentions: 106     Fields:    Translation:HumansAnimals
    109. CRF1 and CRF2 receptors are required for potentiated startle to contextual but not discrete cues. Neuropsychopharmacology. 2009 May; 34(6):1494-503. Risbrough VB, Geyer MA, Hauger RL, Coste S, Stenzel-Poore M, Wurst W, Holsboer F. PMID: 19020499.
      View in: PubMed   Mentions: 23     Fields:    Translation:Animals
    110. Modification of the effects of 5-methoxy-N,N-dimethyltryptamine on exploratory behavior in rats by monoamine oxidase inhibitors. Psychopharmacology (Berl). 2008 Nov; 201(1):55-66. Halberstadt AL, Buell MR, Masten VL, Risbrough VB, Geyer MA. PMID: 18604652.
      View in: PubMed   Mentions: 20     Fields:    Translation:Animals
    111. Spontaneous nicotine withdrawal potentiates the effects of stress in rats. Neuropsychopharmacology. 2008 Aug; 33(9):2131-8. Jonkman S, Risbrough VB, Geyer MA, Markou A. PMID: 18033237.
      View in: PubMed   Mentions: 25     Fields:    Translation:Animals
    112. Selection for contextual fear conditioning affects anxiety-like behaviors and gene expression. Genes Brain Behav. 2007 Nov; 6(8):736-49. Ponder CA, Kliethermes CL, Drew MR, Muller J, Das K, Risbrough VB, Crabbe JC, Gilliam TC, Palmer AA. PMID: 17309658.
      View in: PubMed   Mentions: 38     Fields:    Translation:Animals
    113. Role of dopamine D1 and D2 receptors in CRF-induced disruption of sensorimotor gating. Pharmacol Biochem Behav. 2007 Mar; 86(3):550-8. Vinkers CH, Risbrough VB, Geyer MA, Caldwell S, Low MJ, Hauger RL. PMID: 17324452.
      View in: PubMed   Mentions: 9     Fields:    Translation:Animals
    114. Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets. CNS Neurol Disord Drug Targets. 2006 Aug; 5(4):453-79. Hauger RL, Risbrough V, Brauns O, Dautzenberg FM. PMID: 16918397.
      View in: PubMed   Mentions: 121     Fields:    Translation:HumansAnimalsCells
    115. Role of corticotropin releasing factor in anxiety disorders: a translational research perspective. Horm Behav. 2006 Nov; 50(4):550-61. Risbrough VB, Stein MB. PMID: 16870185.
      View in: PubMed   Mentions: 58     Fields:    Translation:HumansAnimalsCells
    116. Differential contributions of dopamine D1, D2, and D3 receptors to MDMA-induced effects on locomotor behavior patterns in mice. Neuropsychopharmacology. 2006 Nov; 31(11):2349-58. Risbrough VB, Masten VL, Caldwell S, Paulus MP, Low MJ, Geyer MA. PMID: 16855533.
      View in: PubMed   Mentions: 52     Fields:    Translation:Animals
    117. Anxiogenic treatments do not increase fear-potentiated startle in mice. Biol Psychiatry. 2005 Jan 01; 57(1):33-43. Risbrough VB, Geyer MA. PMID: 15607298.
      View in: PubMed   Mentions: 14     Fields:    Translation:Animals
    118. Corticotropin-releasing factor receptors CRF1 and CRF2 exert both additive and opposing influences on defensive startle behavior. J Neurosci. 2004 Jul 21; 24(29):6545-52. Risbrough VB, Hauger RL, Roberts AL, Vale WW, Geyer MA. PMID: 15269266.
      View in: PubMed   Mentions: 52     Fields:    Translation:Animals
    119. Role of corticotropin releasing factor (CRF) receptors 1 and 2 in CRF-potentiated acoustic startle in mice. Psychopharmacology (Berl). 2003 Nov; 170(2):178-87. Risbrough VB, Hauger RL, Pelleymounter MA, Geyer MA. PMID: 12845406.
      View in: PubMed   Mentions: 35     Fields:    Translation:Animals
    120. Cognitive enhancing properties and tolerability of cholinergic agents in mice: a comparative study of nicotine, donepezil, and SIB-1553A, a subtype-selective ligand for nicotinic acetylcholine receptors. Neuropsychopharmacology. 2003 Jul; 28(7):1235-46. Bontempi B, Whelan KT, Risbrough VB, Lloyd GK, Menzaghi F. PMID: 12700710.
      View in: PubMed   Mentions: 29     Fields:    Translation:Animals
    121. GABA-A and 5-HT1A receptor agonists block expression of fear-potentiated startle in mice. Neuropsychopharmacology. 2003 Apr; 28(4):654-63. Risbrough VB, Brodkin JD, Geyer MA. PMID: 12655310.
      View in: PubMed   Mentions: 27     Fields:    Translation:Animals
    122. Selective immunolesioning of the basal forebrain cholinergic neurons in rats: effect on attention using the 5-choice serial reaction time task. Psychopharmacology (Berl). 2002 Oct; 164(1):71-81. Risbrough V, Bontempi B, Menzaghi F. PMID: 12373421.
      View in: PubMed   Mentions: 17     Fields:    Translation:AnimalsCells
    123. Effects of (+/-)-4-[[2-(1-methyl-2-pyrrolidinyl)ethyl]thio]phenol hydrochloride (SIB-1553A), a selective ligand for nicotinic acetylcholine receptors, in tests of visual attention and distractibility in rats and monkeys. J Pharmacol Exp Ther. 2002 Apr; 301(1):284-92. Terry AV, Risbrough VB, Buccafusco JJ, Menzaghi F. PMID: 11907185.
      View in: PubMed   Mentions: 19     Fields:    Translation:Animals
    124. SIB-1553A, (+/-)-4-[[2-(1-methyl-2-pyrrolidinyl)ethyl]thio]phenol hydrochloride, a subtype-selective ligand for nicotinic acetylcholine receptors with putative cognitive-enhancing properties: effects on working and reference memory performances in aged rodents and nonhuman primates. J Pharmacol Exp Ther. 2001 Oct; 299(1):297-306. Bontempi B, Whelan KT, Risbrough VB, Rao TS, Buccafusco JJ, Lloyd GK, Menzaghi F. PMID: 11561092.
      View in: PubMed   Mentions: 12     Fields:    Translation:Animals
    125. Clonidine blocks acquisition but not expression of conditioned opiate withdrawal in rats. Neuropsychopharmacology. 1998 Nov; 19(5):406-16. Schulteis G, Stinus L, Risbrough VB, Koob GF. PMID: 9778662.
      View in: PubMed   Mentions: 11     Fields:    Translation:Animals
    126. Anxiogenic-like effects of spontaneous and naloxone-precipitated opiate withdrawal in the elevated plus-maze. Pharmacol Biochem Behav. 1998 Jul; 60(3):727-31. Schulteis G, Yackey M, Risbrough V, Koob GF. PMID: 9678657.
      View in: PubMed   Mentions: 31     Fields:    Translation:Animals
    127. Interactions between a novel cholinergic ion channel agonist, SIB-1765F and L-DOPA in the reserpine model of Parkinson's disease in rats. J Pharmacol Exp Ther. 1997 Jan; 280(1):393-401. Menzaghi F, Whelan KT, Risbrough VB, Rao TS, Lloyd GK. PMID: 8996220.
      View in: PubMed   Mentions: 4     Fields:    Translation:Animals
    128. Effects of a novel cholinergic ion channel agonist SIB-1765F on locomotor activity in rats. J Pharmacol Exp Ther. 1997 Jan; 280(1):384-92. Menzaghi F, Whelan KT, Risbrough VB, Rao TS, Lloyd GK. PMID: 8996219.
      View in: PubMed   Mentions: 5     Fields:    Translation:Animals
    Victoria's Networks
    Concepts (503)
    Derived automatically from this person's publications.
    _
    Co-Authors (76)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _